The FDA commissioner has resigned, ending a tenure marked by turmoil. The resignation has been reported to follow months of criticism and pressure, with the agency now in a state of transition. The outgoing commissioner's legacy is described as mixed, leaving questions about the agency's unfinished agenda items.